Haemonetics Corporation · NYSE:HAE
AQR Capital Management LLC reported a 6.76% stake in Haemonetics Corporation (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 13, 2026
AQR Capital Management LLC reported a 6.76% stake in Haemonetics Corporation, 3,163,104 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G).
- Stake
- 6.76%
- Shares
- 3,163,104
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AQR Capital Management, LLC | 6.76% | 3,163,104 |
| AQR Capital Management Holdings, LLC | 6.76% | 3,163,104 |
Source
Related
- Haemonetics Corporation
- AQR Capital Management LLC
- Haemonetics Corporation shareholders
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026
- Form 4 · Kroll Mark W · Jul 28, 2026